Pharmafile Logo
Pharmafocus logo
Advanced Search
GSK image

GSK settles cancer patent dispute

March 28, 2012
Research and Development, Sales and Marketing GSK, Genmab, Roche, ofatumumab, patents

GlaxoSmithKline has settled a long-running patent dispute over its cancer treatment ofatumumab.  The US patents, which relate to recombinant antibody …

News

NHS reforms become law

March 28, 2012
Sales and Marketing CCGs, Commissioning Board, Lansley, NHS, PCTs, QIPP, reforms

After 18 months of political wrangling and mass opposition, the government’s reform of the NHS in England has been passed …

News
Amgen picture

Sanofi sets up cholesterol drug showdown with Amgen

March 27, 2012
Research and Development, Sales and Marketing Amgen, BMS, LDL, Lipitor, Merck, Regeneron, Sanofi

Sanofi and Amgen have posted results for their new injectable cholesterol drugs within 24 hours of each other.  Both drugs …

News

Pharma manufacturing news in brief

March 27, 2012
Manufacturing and Production Apotex, Ei Inc, Oxford Pharmascience and Bend Research, PharmaForm

Apotex sues FDA, Ei expands its production facilities in North Carolina, plus new developments at PharmaForm, Oxford Pharmascience and Bend …

News
Merck KGaA image

Merck KGaA manufacturing under scrutiny by FDA

March 27, 2012
Manufacturing and Production FDA, Merck KGaA, Rebif, Violations, manufacturing

The US Food and Drug Administration has asked Merck KGaA to undertake a ‘comprehensive and global assessment’ of its manufacturing …

News

Risk register spells out NHS reform risks

March 27, 2012
Sales and Marketing NHS reforms, commissioning, health bill, risk register

A leaked document that assesses problems with the government’s reform of the NHS has been published by the Guardian. The …

News
Quetiapine image

Teva launches generic Seroquel in UK

March 27, 2012
Sales and Marketing AZ, NHS, Quetiapine, Seroquel, Teva

Teva has launched a generic version of the antipsychotic Seroquel on the same day AstraZeneca loses patent protection on its …

News
FDA image

FDA warns against phthalate use in medicines

March 27, 2012
Manufacturing and Production FDA, SUPAC, manufacturing, phthalates

The Food and Drug Administration has warned pharma companies not to use two phthalates as excipients in both biological products and drugs, …

News

Contract research news in brief

March 27, 2012
Research and Development AMRI, Cetero, Kforce, Particle Sciences and QED Clinical Services, inVentiv Health

Cetero files for bankruptcy after FDA admonishments, AMRI shutters Hungarian facility and inVentiv Health buys Kforce; also updates from Particle …

News

UK government launches new dementia programme

March 26, 2012
Medical Communications, Sales and Marketing Alzheimer's, Cameron, UK, dementia

The government has signalled its intention to boost dementia funding and awareness with its new ‘challenge on dementia’ campaign.  In …

News

Mobile monitoring of asthma ‘no better’ than traditional methods

March 26, 2012
Medical Communications BMJ, Mobile monitoring, apps, asthma, smartphone

Mobile phone monitoring of asthma is ‘more expensive and no better than paper monitoring’, says new research.  Findings published in …

News

HPI strengthens healthcare and pharma presence with new hire

March 26, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

HPI has strengthened its presence in the healthcare and pharma sectors with the appointment of Marianne MacDonell. She will head …

Appointment

UCB nominates new board members

March 26, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing UCB, board members

UCB has nominated Harriet Edelman and Charles-Antoine Janssen to become new members of UCB’s board of directors. The new nominations …

Appointment
NICE hq pic

NICE looking into unlicensed and off-label drug use

March 26, 2012
Sales and Marketing DoH, NICE, off label, off-label, postcode, unlicensed

NICE is reviewing the use of off-label and unlicensed medicines across the NHS in England. This follows a pilot project …

News

Rare diseases – pharma’s new frontier

March 26, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Pharma, CAPS, McConaghie, rare diseases

The last ten years has seen our understanding of rare diseases move ahead rapidly, often thanks to greater understanding of …

Feature
Shire image

Shire signs CNS disorders deal with Heptares

March 23, 2012
Research and Development A2A, CNS, GPCR, Heptares, Shire

Shire is to develop and commercialise a novel adenosine A2A antagonist discovered by Heptares currently in pre-clinical development.UK-based Heptares discovers and …

News

High Court rules against Seroquel XR patent

March 23, 2012
Sales and Marketing Accord, AstraZeneca, Sandoz, Seroquel, Teva

A British High Court has ruled that AstraZeneca’s patent on its new formulation of the antipsychotic Seroquel is invalid. Seroquel …

News

Zaicom appoints Dr Beverly Barr as its new director

March 23, 2012
Business Services, Medical Communications, Sales and Marketing Beverly Barr, Zaicom

Zaicom International has appointed Dr Beverly Barr as its new director and board member. The UK-based med comms group said …

Appointment

Early-stage research gains another funding boost

March 23, 2012
Research and Development, Sales and Marketing GSK, Index Ventures, Janssen, R&D

GlaxoSmithKline and Janssen are among the key investors in a venture capital fund aimed solely at identifying promising pharma start-ups.  …

News

Universal World Events Celebrates Business Wins

March 22, 2012
Sales and Marketing

Universal WorldEvents is delighted to announce a number of recent business development successes in the first two months of 2012. The …

News
Press release
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026